Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Myelodysplastic Syndromes 999Leukemia, Myeloid, Acute 826Leukemia, Myelogenous, Chronic, BCR-ABL Positive 532Leukemia 519Precursor Cell Lymphoblastic Leukemia-Lymphoma 501Myeloproliferative Disorders 438Lymphoma, Non-Hodgkin 339Multiple Myeloma 327Hodgkin Disease 313Leukemia, Lymphocytic, Chronic, B-Cell 304Leukemia, Myelomonocytic, Chronic 299Primary Myelofibrosis 285Lymphoma 267Leukemia, Myeloid, Chronic-Phase 254Leukemia, Myeloid, Accelerated Phase 208Blast Crisis 208Lymphoma, Mantle-Cell 206Lymphoma, Follicular 204Burkitt Lymphoma 200Lymphoma, Large B-Cell, Diffuse 192Lymphoma, B-Cell, Marginal Zone 184Congenital Abnormalities 166Lymphoma, Large-Cell, Immunoblastic 165Polycythemia Vera 162Myelodysplastic-Myeloproliferative Diseases 159Neoplasms, Plasma Cell 152Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 145Anemia, Refractory, with Excess of Blasts 127Thrombocythemia, Essential 125Lymphoma, T-Cell, Cutaneous 124

Interventions

decitabine and cedazuridine drug combination 1Injections 1Decitabine 1Azacitidine 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Accelerated Phase Myeloproliferative Neoplasm × Myeloid × Clear all
NCT07148947 2026-03-04

Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms

University of Washington

Phase 2 Recruiting
27 enrolled
Myeloid

Accelerated Phase Myeloproliferative Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡